DK0864327T3 - Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft - Google Patents
Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræftInfo
- Publication number
- DK0864327T3 DK0864327T3 DK98103410T DK98103410T DK0864327T3 DK 0864327 T3 DK0864327 T3 DK 0864327T3 DK 98103410 T DK98103410 T DK 98103410T DK 98103410 T DK98103410 T DK 98103410T DK 0864327 T3 DK0864327 T3 DK 0864327T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pyrimidine derivatives
- cancer prevention
- prevention drug
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19710435A DE19710435A1 (de) | 1997-03-13 | 1997-03-13 | Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0864327T3 true DK0864327T3 (da) | 2003-02-17 |
Family
ID=7823277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98103410T DK0864327T3 (da) | 1997-03-13 | 1998-02-27 | Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6156755A (es) |
| EP (1) | EP0864327B1 (es) |
| JP (1) | JPH10279482A (es) |
| KR (1) | KR19980080148A (es) |
| CN (1) | CN1193513A (es) |
| AR (1) | AR011190A1 (es) |
| AT (1) | ATE227129T1 (es) |
| AU (1) | AU726089B2 (es) |
| BR (1) | BR9800884A (es) |
| CA (1) | CA2231765A1 (es) |
| CZ (1) | CZ74698A3 (es) |
| DE (2) | DE19710435A1 (es) |
| DK (1) | DK0864327T3 (es) |
| ES (1) | ES2182161T3 (es) |
| HU (1) | HUP9800535A1 (es) |
| PL (1) | PL325327A1 (es) |
| PT (1) | PT864327E (es) |
| RU (1) | RU2209629C2 (es) |
| TR (1) | TR199800436A2 (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE336484T1 (de) | 1998-08-29 | 2006-09-15 | Astrazeneca Ab | Pyrimidine verbindungen |
| DE69933680T2 (de) | 1998-08-29 | 2007-08-23 | Astrazeneca Ab | Pyrimidine verbindungen |
| GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| GB9905075D0 (en) | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
| GB9907658D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Chemical compounds |
| GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
| GB0004886D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004888D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0007371D0 (en) | 2000-03-28 | 2000-05-17 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0016877D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
| GB0021726D0 (en) | 2000-09-05 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| US6716851B2 (en) * | 2000-12-12 | 2004-04-06 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| GB0113041D0 (en) | 2001-05-30 | 2001-07-18 | Astrazeneca Ab | Chemical compounds |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| GB0205688D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| WO2003076434A1 (en) | 2002-03-09 | 2003-09-18 | Astrazeneca Ab | 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity |
| GB0205690D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| RU2376992C2 (ru) * | 2002-07-29 | 2009-12-27 | Райджел Фармасьютикалз, Инк. | Способы лечения или профилактики аутоиммунных заболеваний с помощью соединений 2,4-пиримидиндиамина |
| MXPA05001096A (es) * | 2002-07-29 | 2005-11-23 | Rigel Pharmaceuticals Inc | Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina. |
| GB0311274D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
| GB0311276D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
| GB0323137D0 (en) * | 2003-10-03 | 2003-11-05 | Chang Lisa C W | 2,4,6- Trisubstituted pyrimidines and their different uses |
| US20080058356A1 (en) * | 2003-12-15 | 2008-03-06 | Neurocrine Biosciences, Inc. | 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists |
| TW200528101A (en) | 2004-02-03 | 2005-09-01 | Astrazeneca Ab | Chemical compounds |
| EP1888565B1 (en) * | 2005-04-11 | 2011-03-23 | Almirall, S.A. | 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| US20060293343A1 (en) * | 2005-05-18 | 2006-12-28 | Asahi Kasei Pharma Corporation | Pyrimidine derivatives |
| EP1934213A1 (en) | 2005-09-30 | 2008-06-25 | Astra Zeneca AB | Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
| WO2008070661A1 (en) * | 2006-12-04 | 2008-06-12 | Neurocrine Biosciences, Inc. | Substituted pyrimidines as adenosine receptor antagonists |
| US20100249084A1 (en) * | 2007-03-21 | 2010-09-30 | Youngsheng Chen | Substituted pyrimidines as adenosine receptor antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| DE4025387A1 (de) * | 1990-08-10 | 1992-02-13 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
| AU683620B2 (en) * | 1992-09-28 | 1997-11-20 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
-
1997
- 1997-03-13 DE DE19710435A patent/DE19710435A1/de not_active Withdrawn
-
1998
- 1998-02-27 DE DE59806139T patent/DE59806139D1/de not_active Expired - Fee Related
- 1998-02-27 AT AT98103410T patent/ATE227129T1/de not_active IP Right Cessation
- 1998-02-27 DK DK98103410T patent/DK0864327T3/da active
- 1998-02-27 EP EP98103410A patent/EP0864327B1/de not_active Expired - Lifetime
- 1998-02-27 ES ES98103410T patent/ES2182161T3/es not_active Expired - Lifetime
- 1998-02-27 PT PT98103410T patent/PT864327E/pt unknown
- 1998-03-11 AR ARP980101097A patent/AR011190A1/es unknown
- 1998-03-11 TR TR1998/00436A patent/TR199800436A2/xx unknown
- 1998-03-11 US US09/038,156 patent/US6156755A/en not_active Expired - Fee Related
- 1998-03-11 CA CA002231765A patent/CA2231765A1/en not_active Abandoned
- 1998-03-11 CZ CZ98746A patent/CZ74698A3/cs unknown
- 1998-03-11 HU HU9800535A patent/HUP9800535A1/hu unknown
- 1998-03-12 CN CN98105543A patent/CN1193513A/zh active Pending
- 1998-03-12 BR BR9800884-6A patent/BR9800884A/pt not_active IP Right Cessation
- 1998-03-12 RU RU98105512/14A patent/RU2209629C2/ru not_active IP Right Cessation
- 1998-03-12 KR KR1019980008179A patent/KR19980080148A/ko not_active Application Discontinuation
- 1998-03-12 AU AU58350/98A patent/AU726089B2/en not_active Ceased
- 1998-03-12 JP JP10060757A patent/JPH10279482A/ja active Pending
- 1998-03-13 PL PL98325327A patent/PL325327A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0864327A1 (de) | 1998-09-16 |
| DE19710435A1 (de) | 1998-09-17 |
| KR19980080148A (ko) | 1998-11-25 |
| RU2209629C2 (ru) | 2003-08-10 |
| ES2182161T3 (es) | 2003-03-01 |
| US6156755A (en) | 2000-12-05 |
| CN1193513A (zh) | 1998-09-23 |
| DE59806139D1 (de) | 2002-12-12 |
| HUP9800535A1 (hu) | 2000-11-28 |
| HU9800535D0 (en) | 1998-04-28 |
| CA2231765A1 (en) | 1998-09-13 |
| CZ74698A3 (cs) | 1998-09-16 |
| PT864327E (pt) | 2003-03-31 |
| EP0864327B1 (de) | 2002-11-06 |
| PL325327A1 (en) | 1998-09-14 |
| AU5835098A (en) | 1998-09-17 |
| TR199800436A3 (tr) | 1998-10-21 |
| ATE227129T1 (de) | 2002-11-15 |
| AR011190A1 (es) | 2000-08-02 |
| BR9800884A (pt) | 1999-12-07 |
| TR199800436A2 (xx) | 1998-10-21 |
| AU726089B2 (en) | 2000-11-02 |
| JPH10279482A (ja) | 1998-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0864327T3 (da) | Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft | |
| IS6310A (is) | Kínasólínafleiður til lækninga | |
| ID23874A (id) | Obat | |
| DE122010000011I1 (de) | Flüssige gonadotropinhaltige Arzneimittel | |
| NL300373I2 (nl) | HIV-replicatie-remmende pyrimidinen | |
| ATE256123T1 (de) | Pyrimidonderivate | |
| ID24654A (id) | Formulasi farmasi omeprazola | |
| ATE446955T1 (de) | Chinazolinone derivate | |
| DK1093370T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
| PT1221918E (pt) | Administracao de drogas sub-tenon | |
| ID19343A (id) | Alat penghirup bubuk obat | |
| EE200000383A (et) | Peroraalne farmatseutiline pikendatud vabanemisega annusvorm | |
| DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
| ATE238812T1 (de) | Voriconazol-enthaltende pharmazeutische zubereitungen | |
| NO20040145L (no) | Anvendelse av benzensulfonamidderivater for fremstilling av et medikament | |
| DE69737936D1 (de) | Arzneimittel | |
| DE59915033D1 (de) | Pharmazeutische Zubereitung | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| NO991560L (no) | PDE IV-inhiberende 2-cyanoiminoimidazol-derivater | |
| EE05375B1 (et) | LevosimendaniÁfarmatseutilineÁlahus | |
| NO20001375L (no) | Legemiddelformulering med kontrollert virkestoffrigivning | |
| NO20014926D0 (no) | Farmasöytiske forbindelser | |
| DK0868911T3 (da) | Rapamycinpræparater til oral indgivelse | |
| NO20012976D0 (no) | Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament | |
| ATE295150T1 (de) | Pharmazeutische zusammensetzungen |